"Abstract #577: Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease" by Katherine Tuttle

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Presentation

Abstract #577: Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease

European Association for the Study of Diabetes

Katherine Tuttle, Providence St. Joseph Health
Jonathan Wilson
Kevin Duffin
Fady Botros
Kathleen Kelly-Boruff
Federica Genovese
Morten Karsdal
Yanzhu Lin
Hui-Rong Qian

Link

Document Type

Presentation

Publication Date

9-23-2020

Disciplines

Endocrinology, Diabetes, and Metabolism

Clinical Institute

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Comments

Virtual Meeting

Citation Information

Katherine Tuttle, Jonathan Wilson, Kevin Duffin, Fady Botros, et al.. "Abstract #577: Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease" European Association for the Study of Diabetes (2020)
Available at: http://works.bepress.com/katherine-tuttle/240/